HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Expression of LIN28 and its regulatory microRNAs in adult adrenocortical cancer.

AbstractOBJECTIVE:
LIN28 control cells reprogramming and pluripotency mainly through miRNA regulation and has been overexpressed in many advanced cancers. In this study, we evaluated the prognostic role of LIN28 and its regulatory miRNAs in a large cohort of adrenocortical tumours (ACTs).
PATIENTS AND METHODS:
LIN28 protein expression was assessed in 266 adults ACTs (78 adenomas and 188 carcinomas) from Brazil and Germany. LIN28A and LIN28B gene expression was analysed in 59 ACTs (31 adenomas and 28 carcinomas) and copy number variation in 39 ACTs. In addition, we determined the expression of let-7 family, mir-9, mir-30 and mir-125 in 28 carcinomas.
RESULTS:
LIN28A gene was overexpressed in aggressive ACCs when compared with adenomas and nonaggressive ACCs, but no LIN28A copy number variation was found in ACTs. Unexpectedly, weak LIN28 protein expression was significantly associated with reduced disease-free survival in ACC patients (P = 0·01), but for overall survival only a trend was detectable (P = 0·117). In the multivariate analysis, only Ki67 index ≥10% (HR 4·6, P = 0·000) and weak LIN28 protein expression (HR 2·0, P = 0·03) were independent predictors of recurrence in ACC patients. Interestingly, mir-9 expression, a negative LIN28A/B regulator, was significantly higher in aggressive than in nonaggressive ACCs [2076 (from 36 to 9307) vs 133·4 (from 2·4 to 5193); P = 0·011] and was highly associated with reduced overall (P = 0·01) and disease-free survival (P = 0·01). However, mir-9 prognostic role should be further evaluated in a larger cohort.
CONCLUSION:
Weak LIN28 protein expression was associated with recurrence in ACCs. Additionally, overexpression of mir-9, a negative LIN28A regulator, was associated with poor outcome.
AuthorsAndré M Faria, Silviu Sbiera, Tamaya C Ribeiro, Iberê C Soares, Beatriz M P Mariani, Daniel S Freire, Gabriela R V de Sousa, Antônio M Lerario, Cristina L Ronchi, Timo Deutschbein, Alda Wakamatsu, Venancio A F Alves, Maria Claudia N Zerbini, Berenice B Mendonca, Maria Candida B V Fragoso, Ana Claudia Latronico, Martin Fassnacht, Madson Q Almeida
JournalClinical endocrinology (Clin Endocrinol (Oxf)) Vol. 82 Issue 4 Pg. 481-8 (Apr 2015) ISSN: 1365-2265 [Electronic] England
PMID25200669 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2014 John Wiley & Sons Ltd.
Chemical References
  • Ki-67 Antigen
  • Lin28A protein, human
  • MicroRNAs
  • RNA-Binding Proteins
Topics
  • Adenoma (genetics, metabolism)
  • Adrenal Cortex Neoplasms (genetics, metabolism)
  • Adrenocortical Carcinoma (genetics, metabolism)
  • Adult
  • Brazil
  • Cohort Studies
  • DNA Copy Number Variations
  • Disease-Free Survival
  • Female
  • Gene Expression Profiling
  • Gene Expression Regulation, Neoplastic
  • Genome-Wide Association Study
  • Germany
  • Humans
  • Ki-67 Antigen (metabolism)
  • Male
  • MicroRNAs (metabolism)
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Prognosis
  • RNA-Binding Proteins (genetics, metabolism)
  • Real-Time Polymerase Chain Reaction
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: